Why Pharma has to stop playing solo. Richard Bergstrom, Director General, EFPIA




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Why Pharma has to stop playing solo. Richard Bergstrom, Director General, EFPIA
Released on: June 30, 2014. © PTV
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Reducing inequalities in health, accelerating patients’ access to innovative medicines and improving patient safety – these are the primary commitments of EFPIA.
  • Summary
  • Transcript
  • Participants
  • Company
Reducing inequalities in health, accelerating patients’ access to innovative medicines and improving patient safety – these are the primary commitments of EFPIA. Richard Bergstrom, Director General, talks to Fintan Walton during Eyeforpharma in Barcelona about how, by working in partnership with all relevant healthcare stakeholders, they seek to develop practical solutions to make these goals a reality. EFPIA believe that Europe’s citizens support these commitments, creating a mutual agenda and therefore call upon stakeholders to collaborate in implementing policies that recognise the pharmaceutical industry’s role in improving European public health, economic wealth, and in enhancing Europe’s industrial and science base. EFPIA believe that Europe’s citizens support these commitments, creating a mutual agenda and therefore call upon stakeholders to collaborate in implementing policies that recognise the pharmaceutical industry’s role in improving European public health, economic wealth, and in enhancing Europe’s industrial and science base.
Reducing inequalities in health, accelerating patients’ access to innovative medicines and improving patient safety – these are the primary commitments of EFPIA. Richard Bergstrom, Director General, talks to Fintan Walton during Eyeforpharma in Barcelona about how, by working in partnership with all relevant healthcare stakeholders, they seek to develop practical solutions to make these goals a reality. EFPIA believe that Europe’s citizens support these commitments, creating a mutual agenda and therefore call upon stakeholders to collaborate in implementing policies that recognise the pharmaceutical industry’s role in improving European public health, economic wealth, and in enhancing Europe’s industrial and science base.
Richard Bergstrom
EFPIA
EFPIA
EFPIA brings together 33 European national pharmaceutical industry associations as well as 40 leading companies undertaking research, development and the manufacture in Europe of medicinal products for human use.